Amicus Therapeutics Inc (NASDAQ: FOLD) is -28.61% lower on its value in year-to-date trading and has touched a low of $9.02 and a high of $14.57 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FOLD stock was last observed hovering at around $9.83 in the last trading session, with the day’s gains setting it 0.3%.
Currently trading at $10.13, the stock is 2.76% and -4.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.25 million and changing 3.05% at the moment leaves the stock -5.92% off its SMA200. FOLD registered -9.71% loss for a year compared to 6-month gain of -2.60%. The firm has a 50-day simple moving average (SMA 50) of $10.5872 and a 200-day simple moving average (SMA200) of $10.7854.
The stock witnessed a -7.83% loss in the last 1 month and extending the period to 3 months gives it a -10.12%, and is 3.47% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.97% over the week and 3.15% over the month.
Amicus Therapeutics Inc (FOLD) has around 517 employees, a market worth around $3.03B and $493.67M in sales. Fwd P/E is 69.48. Profit margin for the company is -21.21%. Distance from 52-week low is 12.31% and -30.47% from its 52-week high. The company has generated returns on investments over the last 12 months (-17.02%).
with sales reaching $147.37M over the same period.The EPS is expected to grow by 60.93% this year, but quarterly earnings will post 31.68% year-over-year. Quarterly sales are estimated to grow 28.06% in year-over-year returns.
Amicus Therapeutics Inc (FOLD) Top Institutional Holders
383.0 institutions hold shares in Amicus Therapeutics Inc (FOLD), with institutional investors hold 106.02% of the company’s shares. The shares outstanding are 298.69M, and float is at 291.20M with Short Float at 7.21%. Institutions hold 105.24% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 28.59 million shares valued at $283.6 million. The investor’s holdings represent 9.4382% of the FOLD Shares outstanding. As of 2024-06-30, the second largest holder is PERCEPTIVE ADVISORS LLC with 28.06 million shares valued at $278.33 million to account for 9.2629 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 27.4 million shares representing 9.0458% and valued at over $271.81 million, while BLACKROCK INC. holds 8.046 of the shares totaling 24.37 million with a market value of $241.77 million.
Amicus Therapeutics Inc (FOLD) Insider Activity
The most recent transaction is an insider sale by Campbell Bradley L, the company’s President and CEO. SEC filings show that Campbell Bradley L sold 7,500 shares of the company’s common stock on Dec 02 ’24 at a price of $10.02 per share for a total of $75124.0. Following the sale, the insider now owns 0.89 million shares.
Still, SEC filings show that on Nov 06 ’24, Campbell Bradley L (President and CEO) disposed off 7,901 shares at an average price of $12.50 for $98800.0. The insider now directly holds 886,654 shares of Amicus Therapeutics Inc (FOLD).
